Fernanda Flygare: HI-PEITHO Trial Highlights Benefits of EKOS-Assisted Catheter-Directed Thrombolysis in PE
Fernanda Flygare, Marketing manager at Boston Scientific, shared on LinkedIn:
”In intermediate-risk pulmonary embolism, anticoagulation alone may not always be sufficient to prevent hemodynamic deterioration.
The HI-PEITHO trial provided important evidence showing that ultrasound-assisted catheter-directed thrombolysis with the EKOS system, combined with anticoagulation, reduced clinically relevant outcomes while contributing to greater patient stability without increasing major bleeding.
In this video, Dr. Felipe Nasser, specialist in Interventional Radiology and Endovascular Surgery, shares his perspective on how these findings may translate into clinical practice and impact patient management.
At Boston Scientific, we remain committed to advancing continuous medical education and fostering high-level clinical discussions that support evidence-based decision-making and ultimately improve patient care.
Congratulations to everyone involved in bringing valuable scientific exchange and education to the medical community.
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at ISTH 2026
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2